Literature DB >> 17488797

Vitamin D 1alpha-hydroxylase gene mutations in patients with 1alpha-hydroxylase deficiency.

Chan Jong Kim1, Larry E Kaplan, Farzana Perwad, Ningwu Huang, Amita Sharma, Yong Choi, Walter L Miller, Anthony A Portale.   

Abstract

CONTEXT: Vitamin D 1alpha-hydroxylase deficiency, also known as vitamin D-dependent rickets type 1, is an autosomal recessive disorder characterized by the early onset of rickets with hypocalcemia and is caused by mutations of the 25-hydroxyvitamin D 1alpha-hydroxylase (1alpha-hydroxylase, CYP27B1) gene. The human gene encoding the 1alpha-hydroxylase is 5 kb in length, located on chromosome 12, and comprises nine exons and eight introns. We previously isolated the human 1alpha-hydroxylase cDNA and gene and identified 19 different mutations in 25 patients with 1alpha-hydroxylase deficiency. OBJECTIVES, PATIENTS, AND METHODS: We analyzed the 1alpha-hydroxylase gene of 10 patients, five from Korea, two from the United States, and one each from Argentina, Denmark, and Morocco, all from nonconsanguineous families. Each had clinical and radiographic features of rickets, hypocalcemia, and low serum concentrations of 1,25-dihydroxyvitamin D(3).
RESULTS: Direct sequencing identified the responsible 1alpha-hydroxylase gene mutations in 19 of 20 alleles. Four novel and four known mutations were identified. The new mutations included a nonsense mutation in exon 6, substitution of adenine for guanine (2561G-->A) creating a stop signal at codon 328; deletion of adenine in exon 9 (3922delA) causing a frameshift; substitution of thymine for cytosine in exon 2 (1031C-->T) causing the amino acid change P112L; and a splice site mutation, substitution of adenine for guanine in the first nucleotide of intron 7 (IVS7+1 G-->A) causing a frameshift.
CONCLUSIONS: Mutations in the 1alpha-hydroxylase gene previously were identified in 44 patients, to which we add 10 more. The studies show a strong correlation between 1alpha-hydroxylase mutations and the clinical findings of 1alpha-hydroxylase deficiency.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17488797     DOI: 10.1210/jc.2006-2664

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  23 in total

1.  Novel vitamin D 1α-hydroxylase gene mutations in a Chinese vitamin-D-dependent rickets type I patient.

Authors:  Lihua Cao; Fang Liu; Yu Wang; Jian Ma; Shusen Wang; Libo Wang; Yang Zhang; Chen Chen; Yang Luo; Hongwei Ma
Journal:  J Genet       Date:  2011-08       Impact factor: 1.166

Review 2.  Cytochrome P450-mediated metabolism of vitamin D.

Authors:  Glenville Jones; David E Prosser; Martin Kaufmann
Journal:  J Lipid Res       Date:  2013-04-06       Impact factor: 5.922

Review 3.  Human cytochrome P450 enzymes 5-51 as targets of drugs and natural and environmental compounds: mechanisms, induction, and inhibition - toxic effects and benefits.

Authors:  Slobodan P Rendic; F Peter Guengerich
Journal:  Drug Metab Rev       Date:  2018-08       Impact factor: 4.518

4.  Mutation prediction by PolyPhen or functional assay, a detailed comparison of CYP27B1 missense mutations.

Authors:  Minjing Zou; Essa Y Baitei; Ali S Alzahrani; Ranjit S Parhar; Futwan A Al-Mohanna; Brian F Meyer; Yufei Shi
Journal:  Endocrine       Date:  2011-05-21       Impact factor: 3.633

Review 5.  Human cytochromes P450 in health and disease.

Authors:  Daniel W Nebert; Kjell Wikvall; Walter L Miller
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2013-01-06       Impact factor: 6.237

Review 6.  The role of vitamin D receptor mutations in the development of alopecia.

Authors:  Peter J Malloy; David Feldman
Journal:  Mol Cell Endocrinol       Date:  2011-06-13       Impact factor: 4.102

7.  Craniofacial and dental characteristics of patients with vitamin-D-dependent rickets type 1A compared to controls and patients with X-linked hypophosphatemia.

Authors:  Hans Gjørup; Signe Sparre Beck-Nielsen; Dorte Haubek
Journal:  Clin Oral Investig       Date:  2017-06-12       Impact factor: 3.573

Review 8.  Genetic disorders and defects in vitamin d action.

Authors:  Peter J Malloy; David Feldman
Journal:  Endocrinol Metab Clin North Am       Date:  2010-06       Impact factor: 4.741

9.  Analysis of CYP27B1, encoding 25-hydroxyvitamin D-1alpha-hydroxylase, as a candidate tumor suppressor gene in primary and severe secondary/tertiary hyperparathyroidism.

Authors:  Kelly Lauter; Andrew Arnold
Journal:  J Bone Miner Res       Date:  2009-01       Impact factor: 6.741

10.  Mutation update and long-term outcome after treatment with active vitamin D3 in Chinese patients with pseudovitamin D-deficiency rickets (PDDR).

Authors:  Y Chi; J Sun; L Pang; R Jiajue; Y Jiang; O Wang; M Li; X Xing; Y Hu; X Zhou; X Meng; W Xia
Journal:  Osteoporos Int       Date:  2018-10-31       Impact factor: 4.507

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.